# Murex Biotech (Murex Biotech Limited)

Private limited company registered in Maidenhead, classed under “Other manufacturing n.e.c.”.

- Company number: 02670649
- Status: Active
- Type: Private limited company
- Incorporated: 12 December 1991
- Registered office: Abbott House Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE
- Location: Maidenhead, Berkshire
- Activity: Other manufacturing n.e.c.

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Murex Biotech do?

Private limited company registered in Maidenhead, classed under “Other manufacturing n.e.c.”.

### How much turnover does Murex Biotech make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/murex-biotech-02670649

### Is Murex Biotech profitable?

Murex Biotech's profit isn't public: small companies may file without a profit and loss account.

### Who runs and owns Murex Biotech?

Its directors are Kevan Gogay, Ross Iain Campbell, Michael Robert Kendall Clayton, James Russell Wenner. Its owners are shown to subscribers.

### Where is Murex Biotech based?

Its registered office is Abbott House Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, in Maidenhead, Berkshire.

### When was Murex Biotech founded?

Murex Biotech Limited was incorporated on 12 December 1991.

### Is Murex Biotech still trading?

The register lists Murex Biotech Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-07-29: Previous accounting period extended from 31 December 2025 to 30 June 2026
- 2025-12-15: Appointment of Mr James Wenner as a director on 10 December 2025
- 2025-12-15: Termination of appointment of Alison Elizabeth Davies as a director on 10 December 2025
- 2025-09-05: Full accounts made up to 31 December 2024
- 2025-05-01: Appointment of Mr Ross Iain Campbell as a director on 25 April 2025
- 2025-04-30: Termination of appointment of Neil Harris as a director on 25 April 2025
- 2024-07-22: Full accounts made up to 31 December 2023
- 2023-10-25: Appointment of Mrs Alison Elizabeth Davies as a director on 15 October 2023
- 2023-10-25: Termination of appointment of John Arthur Mccoy Jr as a director on 15 October 2023
- 2023-08-24: Full accounts made up to 31 December 2022
- 2022-09-27: Appointment of John Arthur Mccoy Jr as a director on 19 September 2022
- 2022-09-27: Termination of appointment of Karen Ann Krammer as a director on 19 September 2022
- 2022-08-25: Full accounts made up to 31 December 2021
- 2021-10-07: Full accounts made up to 31 December 2020
- 2021-09-17: Withdrawal of a person with significant control statement on 17 September 2021
- 2020-10-07: Full accounts made up to 31 December 2019
- 2020-05-14: Appointment of Mr Michael Robert Kendall Clayton as a director on 23 March 2020
- 2020-05-06: Termination of appointment of Georgios Mountrichas as a director on 23 March 2020
- 2020-05-06: Appointment of Mrs Karen Ann Krammer as a director on 1 March 2020
- 2020-05-04: Termination of appointment of Brian Yoor as a director on 29 February 2020
- 2019-10-04: Full accounts made up to 31 December 2018
- 2018-11-23: Appointment of Mr Georgios Mountrichas as a director on 27 September 2018
- 2018-11-21: Termination of appointment of Gary James Hall as a director on 27 September 2018
- 2018-10-11: Appointment of Mr. Neil Harris as a director on 31 August 2018
- 2018-10-05: Termination of appointment of Susan Michelle Hudson as a director on 31 August 2018

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/murex-biotech-02670649